iMDx signs specimen collection agreement with Quest for GraftAssureCore test

Insight Molecular Diagnostics Inc.

Entered Specimen Collection Agreement with Quest Diagnostics for services supporting GraftAssureCoreTM test.
GraftAssureCore is a blood test measuring donor-derived cell-free DNA (dd-cfDNA) via PCR platform.
Agreement covers specimen collection-related services to commercialize the test.
No financial terms or duration of the agreement disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.